metaraminol has been researched along with Infarct in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JASMIN, G | 1 |
| BAJUSZ, E | 1 |
| Nelson, SR | 1 |
2 other studies available for metaraminol and Infarct
| Article | Year |
|---|---|
[PATHOGENIC STUDY OF CARDIAC, RENAL AND MUSCULAR LESIONS INDUCED IN THE RAT BY METHOXAMINE AND METARAMINOL].
Topics: Adrenalectomy; Coronary Vessels; Histamine Release; Infarction; Ischemia; Kidney; Metaraminol; Metho | 1964 |
Effect of drugs on experimental brain edema in mice.
Topics: Acetazolamide; Animals; Brain; Brain Edema; Cortisone; Dextrans; Disease Models, Animal; Hexamethoni | 1974 |